Middle East and Africa Vaccine Administration Devices Market, By Product (Syringes, Auto Injectors, Jet Injectors, Micro Needles, Inhalation/Pulmonary Delivery, Microinjection System, Pen Injector Devices, Biodegradable Implants, Electroporation-Based Needle Free Injection Systems, Buccal /Sublingual Vaccine Delivery Systems, Autoinjector Trainer Devices and Others Devices), Route of Administration (Intramuscular, Subcutaneous, Intradermal), Type (Marketed Vaccines and Clinical-Stage Vaccines (Electroporation)), Brand (BD Accuspray Nasal Spray System, BD Hypak for Vaccines Glass Pre-Fillable Syringe System, BD Uniject Auto-Disable Pre-Fillable Injection System, Gx InnoSafe, Gx RTF ClearJect, Plajex, Others), Dosage (Fixed and Variable), Vaccine Type (Bivalent Oral PolioVaccine, B.C.G. Vaccine, Tetanus-Diphtheria Vaccine, DTP-HEPB-HIB Vaccine, Influenza Vaccine, Pneumococcal Conjugate Vaccine, Measles Vaccine, Others), Modality (Automatic Vaccine Administration Device and Manual Vaccine Administration Device), Usability (Disposable and Reusable), End User (Hospitals, Community Centers, Homecare Setting, Research and Academic Institutes, Ambulatory Surgical Center, Others), Distribution Channel (Direct Tender, Retail Sales) – Industry Trends and Forecast to 2030.
Middle East and Africa Vaccine Administration Devices Market Analysis and Size
Increasing immunization programs and campaigns and developing novel vaccines are the primary drivers which boosted the market's demand in the forecast period 2023-2030. Several technological advancements to efficiently deliver vaccines are anticipated to boost the market growth. Biotech, pharmaceutical companies, and governments globally are working towards the strategy for supply chain challenges in vaccine delivery and developing effective vaccinations.
Data Bridge Market Research analyses a growth rate in the vaccine administration devices market in the forecast period 2023-2030. The expected CAGR of the vaccine administration devices market tends to be around 4.40% in the mentioned forecast period. The market was valued at USD 100.45 million in 2022 and would grow to USD 141.76 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Middle East and Africa Vaccine Administration Devices Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Syringes, Autoinjectors, Jet Injectors, Micro Needles, Inhalation/Pulmonary Delivery, Microinjection System, Pen Injector Devices, Biodegradable Implants, Electroporation-Based Needle Free Injection Systems, Buccal /Sublingual Vaccine Delivery Systems, Autoinjector Trainer Devices and Others Devices), Route of Administration (Intramuscular, Subcutaneous, Intradermal), Type (Marketed Vaccines and Clinical-Stage Vaccines (Electroporation)), Brand (BD Accuspray Nasal Spray System, BD Hypak for Vaccines Glass Pre-Fillable Syringe System, BD Uniject Auto-Disable Pre-Fillable Injection System, Gx InnoSafe, Gx RTF ClearJect, Plajex, Others), Dosage (Fixed and Variable), Vaccine Type (Bivalent Oral PolioVaccine, B.C.G. Vaccine, Tetanus-Diphtheria Vaccine, DTP-HEPB-HIB Vaccine, Influenza Vaccine, Pneumococcal Conjugate Vaccine, Measles Vaccine, Others), Modality (Automatic Vaccine Administration Device and Manual Vaccine Administration Device), Usability (Disposable and Reusable), End User (Hospitals, Community Centers, Homecare Setting, Research and Academic Institutes, Ambulatory Surgical Center, Others), Distribution Channel (Direct Tender, Retail Sales)
|
|
Countries Covered
|
Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (M.E.A.) as a part of Middle East and Africa (M.E.A.)
|
|
Market Players Covered
|
B.D. (U.S.), INOVIO Pharmaceuticals (U.S.), Vaxxas (U.S.), Gerresheimer AG (Germany), Corium Inc. (U.S.), Enesi (U.S.), Micropoint Technologies (Singapore), SCHOTT AG (Germany), 3M (U.S.), Mystic Pharmaceuticals (U.S.), NanoPass Rev (U.S.), Terumo Middle East and Africa NV (Belgium), D'Antonio Consultants International, Inc. (U.S.), West Pharmaceutical Services, Inc. (U.S.)., Mylan N.V. (U.S.), Medical International Technologies Inc. (Canada), Antares Pharma (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Vaccines are known as a set of biological preparations that protect humans from viruses and other bacteria-related infections. Some are inactivated/killed vaccines, live/attenuated vaccines, toxoid vaccines, and conjugate vaccines. Vaccines are administered intramuscularly or subcutaneously using a syringe or needle. Furthermore, needle-free technologies are the unique vaccine administration technologies as they are highly effective in mass immunization programs, reducing the risk of needle stick injuries and the consequences of many needles use.
Middle East and Africa Vaccine Administration Devices Market Dynamics
Drivers
- Growing Demand for Intradermal Vaccination
The intradermal route of administration has attracted much attention in the past few years because of benefits such as improved safety, dose sparing, and improved access to vaccines. These factors are anticipated to lead to market growth over the following years. Additionally, a rise in the studies of alternative methods for intradermal administration with several novel devices, such as jet injectors and microneedles, is expected to enhance market growth.
- Increasing Number of Immunization Programs
The increasing number of immunization programs and the wide availability of syringes is anticipated to play a major role in the market's growth. For instance, with the ongoing large-scale vaccination programs in this region, syringes are being used widely in delivering vaccines; therefore, the production of syringes has increased significantly. For instance, Hindustan Syringes & Medical Devices Ltd (H.M.D.) received orders from the Indian government to supply 256 million auto-disposable needles in 2021, earlier H.M.D. had received an order of 177.5 million 0.5 mL auto-disposable syringes from the Indian government during COVID-19 pandemic. Thus, this boosts market growth.
Opportunities
- Increasing Rate of Product Launches
An increasing number of product launches associated with vaccines help surge market growth. For instance, vaccines developed by the Serum Institute of India acquired a 50% share in a pharma packing firm, Schott Kaisha, in 2021. This initiative positions the Serum Institute of India in a joint venture with Schott AG, which is a specialty glass company based in Germany. Moreover, numerous initiatives by government agencies to develop new vaccines offer opportunities for growth in the market. Thus, this factor increases the market growth.
- Increasing Healthcare Expenditure from Different Organizations
Immunization coverage is increasing with financial support from international organizations such as Bill & Melinda Gates Foundation, GAVI Alliance, and Path. More vaccines, including those for life-threatening diseases, are increasingly accessible to the population. In underdeveloped and developing nations, innovative funding mechanisms are applied to increase vaccination coverage and provide new vaccines. Furthermore, Global Alliance for Vaccines and Immunizations (GAVI) extended its support in June 2017. This will make the vaccine available to millions of children through the routine immunization program to eliminate polio. Thus, this factor increases the growth of the market.
Restraints/Challenges
- Side-Effects of Vaccine Administration Devices
Numerous side effects associated with vaccine administration devices limit the market growth. Effects such as redness and soreness at the injection site or fever and allergic reactions are the primary effects. Additionally, needle-free injections have a huge drawback with clinical concerns. The high-pressure delivery of drugs can damage fragile molecules under the skin layer, mainly in administering monoclonal antibodies. All these factors hamper the growth of the market.
This vaccine administration devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the vaccine administration devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In 2021, Midas Pharma and Gerresheimer formed a strategic partnership for developing and marketing the new-generation autoinjector. The go-to-market approach for the auto-injector combines the strengths of both companies- Gerresheimer as a solution provider for medical devices and primary packaging solutions and Midas Pharma as an experienced facilitator for global pharma projects and provider of products and services along the pharmaceutical value chain.
Middle East and Africa Vaccine Administration Devices Market Scope
The vaccine administration devices market is segmented on the basis of product, route of administration, type, brand, dosage, vaccine type, modality, usability, end user, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Syringes
- Auto Injectors
- Jet Injectors
- Micro Needles
- Inhalation/Pulmonary Delivery
- Microinjection System
- Pen Injector Devices
- Biodegradable Implants
- Electroporation-Based Needle Free Injection Systems
- Buccal /Sublingual Vaccine Delivery Systems
- Autoinjector Trainer Devices
- Others Devices
Route of Administration
- Intramuscular
- Subcutaneous
- Intradermal
Type
- Marketed Vaccines
- Clinical-Stage Vaccines (Electroporation)
Brand
- BD Accuspray Nasal Spray System
- BD Hypak for Vaccines Glass Pre-Fillable Syringe System
- BD Uniject Auto-Disable Pre-Fillable Injection System
- Gx InnoSafe
- Gx RTF ClearJect, Plajex
- Others
Dosage
- Fixed
- Variable
Vaccine Type
- Bivalent Oral PolioVaccine
- B.C.G. Vaccine
- Tetanus-Diphtheria Vaccine
- DTP-HEPB-HIB Vaccine
- Influenza Vaccine
- Pneumococcal Conjugate Vaccine
- Measles Vaccine
- Others
Modality
- Automatic Vaccine Administration Device
- Manual Vaccine Administration Device
Usability
- Disposable
- Reusable
End User
- Hospitals
- Community Centers
- Homecare Setting
- Research and Academic Institutes
- Ambulatory Surgical Center
- Others
Distribution Channel
- Direct Tender
- Retail Sales
Vaccine Administration Devices Market Regional Analysis/Insights
The vaccine administration devices market is analyzed and market size insights and trends are provided by product, route of administration, type, brand, dosage, vaccine type, modality, usability, end user, and distribution channel as referenced above.
The major countries covered in the vaccine administration devices market report are Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (M.E.A.) as a part of Middle East and Africa (M.E.A.)
Saudi Arabia is expected to witness the fastest growth rate during the forecast period due to a large patient pool, increasing target population, high unmet needs, and improving infrastructure in the region. Also, unhealthy lifestyles and increase in the elderly population who are vulnerable to infectious diseases are leading to the increased incidence of diseases.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of Middle East and Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Middle East and Africa Vaccine Administration Devices Market Share Analysis
The vaccine administration devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Middle East and Africa presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to vaccine administration devices market
Key players operating in the vaccine administration devices market include:
- Medtronic (Ireland)
- Stening S.R.L. (Argentina)
- Cook (U.S.)
- Bicakcilar Medical (Istanbul)
- TROGE MEDICAL GmbH (Germany)
- Henan Tuoren Medical Device Co., Ltd. (China)
- Fisher & Paykel Healthcare Limited (new Zealand)
- Medis Medical (U.K.) Ltd (U.K.)
- Pulmodyne, Inc. (U.S.)
- Fuji Systems (Japan)
- DEAS S.R.L. (Italy)
- Sterimed Group (India)
- ConvaTec Group PLC (U.K.)
- Smiths Medical (U.K.)
- Andreas Fahl Medizintechnik – Vertrieb GmbH (Germany)
- Boston Medical Products Inc. (U.S.)
- TRACOE medical GmbH (Germany)
- Teleflex Incorporated (U.S.)
- Well Lead Medical Co., Ltd (China)
SKU-